CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.54
-0.60 (-7.37%)
At close: Aug 14, 2026, 4:00 PM EDT
7.59
+0.05 (0.68%)
After-hours: Aug 14, 2026, 5:55 PM EDT
CorMedix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 256.69 | 144.84 | 40.65 | 43.64 | 43.15 | 53.32 |
Short-Term Investments | - | 3.69 | 11.04 | 32.39 | 15.64 | 12.15 |
Cash & Short-Term Investments | 256.69 | 148.53 | 51.69 | 76.03 | 58.79 | 65.47 |
Cash Growth | 34.60% | 187.36% | -32.02% | 29.32% | -10.20% | 41.24% |
Receivables | 161.31 | 171.23 | 51.65 | - | - | 0.05 |
Inventory | 38.58 | 29.72 | 7.6 | 2.11 | - | 0 |
Prepaid Expenses | 23.32 | 16.92 | 3.63 | 0.76 | 0.62 | 0.77 |
Restricted Cash | 0.66 | 0.66 | - | 0.08 | 0.12 | 0.13 |
Other Current Assets | - | - | - | 0.47 | 0.01 | 0.05 |
Total Current Assets | 480.55 | 367.05 | 114.58 | 79.45 | 59.55 | 66.47 |
Property, Plant & Equipment | 7.85 | 9.93 | 2.32 | 2.51 | 2.38 | 2.37 |
Long-Term Investments | - | 10.36 | - | - | - | - |
Goodwill | 30 | 30 | - | - | - | - |
Other Intangible Assets | 358.47 | 379.07 | 1.84 | - | - | - |
Long-Term Deferred Tax Assets | - | 16.28 | - | - | - | - |
Other Long-Term Assets | 27.17 | 13.45 | 0.11 | 0.1 | 0.1 | 0.1 |
Total Assets | 904.05 | 826.14 | 118.85 | 82.06 | 62.04 | 68.95 |
Accounts Payable | 10.24 | 7.88 | 1.72 | 4.28 | 2.2 | 2.21 |
Accrued Expenses | 160.19 | 148.36 | 29.95 | 6.97 | 3.97 | 3.01 |
Current Portion of Leases | - | 1.45 | 0.17 | 0.15 | 0.13 | 0.12 |
Current Income Taxes Payable | 13.05 | 12.76 | - | - | - | - |
Other Current Liabilities | 3.91 | 3.82 | 2 | - | - | - |
Total Current Liabilities | 187.4 | 174.27 | 33.84 | 11.4 | 6.31 | 5.35 |
Long-Term Debt | 145.15 | 144.63 | - | - | - | - |
Long-Term Leases | 2.31 | 2.84 | 0.35 | 0.52 | 0.67 | 0.8 |
Other Long-Term Liabilities | 107.71 | 99.1 | - | - | - | - |
Total Liabilities | 443.22 | 420.84 | 34.19 | 11.92 | 6.98 | 6.15 |
Common Stock | 0.08 | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 |
Additional Paid-In Capital | 572.74 | 581.8 | 424.13 | 391.69 | 330.29 | 308.33 |
Retained Earnings | -111.99 | -176.58 | -339.63 | -321.7 | -275.36 | -245.66 |
Comprehensive Income & Other | 0 | 0 | 0.09 | 0.09 | 0.08 | 0.09 |
Total Common Equity | 460.83 | 405.31 | 84.66 | 70.14 | 55.06 | 62.8 |
Shareholders' Equity | 460.83 | 405.31 | 84.66 | 70.14 | 55.06 | 62.8 |
Total Liabilities & Equity | 904.05 | 826.14 | 118.85 | 82.06 | 62.04 | 68.95 |
Total Debt | 147.46 | 148.91 | 0.52 | 0.67 | 0.8 | 0.92 |
Net Cash (Debt) | 109.24 | 9.98 | 51.17 | 75.36 | 57.99 | 64.54 |
Net Cash Growth | -42.59% | -80.50% | -32.10% | 29.96% | -10.15% | 42.43% |
Net Cash Per Share | 1.20 | 0.12 | 0.87 | 1.48 | 1.44 | 1.71 |
Filing Date Shares Outstanding | 77.94 | 79.05 | 65.18 | 54.98 | 44.48 | 38.71 |
Total Common Shares Outstanding | 77.67 | 79.26 | 64.41 | 54.94 | 42.79 | 38.06 |
Working Capital | 293.16 | 192.78 | 80.74 | 68.05 | 53.24 | 61.12 |
Book Value Per Share | 5.93 | 5.11 | 1.31 | 1.28 | 1.29 | 1.65 |
Tangible Book Value | 72.36 | -3.77 | 82.81 | 70.14 | 55.06 | 62.8 |
Tangible Book Value Per Share | 0.93 | -0.05 | 1.29 | 1.28 | 1.29 | 1.65 |